Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 4 October 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 190 pages)

 

Export 7 results:
Author Title [ Type(Desc)] Year
Filters: Author is Boivin, J. F.  [Clear All Filters]
Journal Article
L. Azoulay, Yin, H., Benayoun, S., Renoux, C., Boivin, J. F., and Suissa, S., Androgen-deprivation therapy and the risk of stroke in patients with prostate cancer, Eur Urol, vol. 60, pp. 1244-50, 2011.
C. Renoux, Dell'Aniello, S., Saarela, O., Filion, K. B., and Boivin, J. F., Antiepileptic drugs and the risk of ischaemic stroke and myocardial infarction: a population-based cohort study, BMJ Open, vol. 5, p. e008365, 2015.
C. Renoux, Vahey, S., Dell'Aniello, S., and Boivin, J. F., Association of Selective Serotonin Reuptake Inhibitors With the Risk for Spontaneous Intracranial Hemorrhage, JAMA Neurol, vol. 74, pp. 173-180, 2017.
A. Douros, Dell'Aniello, S., Dehghan, G., Boivin, J. F., and Renoux, C., Degree of serotonin reuptake inhibition of antidepressants and ischemic risk: A cohort study, Neurology, vol. 93, pp. e1010-e1020, 2019.
J. W. Wu, Azoulay, L., Majdan, A., Boivin, J. F., Pollak, M., and Suissa, S., Long-Term Use of Long-Acting Insulin Analogs and Breast Cancer Incidence in Women With Type 2 Diabetes, J Clin Oncol, vol. 35, pp. 3647-3653, 2017.
K. B. Filion, Joseph, L., Boivin, J. F., Suissa, S., and Brophy, J. M., Thiazolidinediones and the risk of incident congestive heart failure among patients with type 2 diabetes mellitus, Pharmacoepidemiol Drug Saf, vol. 20, pp. 785-96, 2011.
K. B. Filion, Joseph, L., Boivin, J. F., Suissa, S., and Brophy, J. M., Trends in the prescription of anti-diabetic medications in the United Kingdom: a population-based analysis, Pharmacoepidemiol Drug Saf, vol. 18, pp. 973-6, 2009.
[Page last reviewed 4 October 2019]